Studies with Efemia

Studies and results

Efemia bladder support has been proven to be effective and user-friendly in several studies with different target groups.

A significant proportion of the participants in these studies state that they will continue to use the product as well as recommend it to friends and acquaintances.

Clinical study (completed in February 2018)

In a randomised, controlled multicentre study with Efemia, in which 97 women with stress urinary incontinence (SUI) participated, the product was shown to reduce urine leakage by an average of 77% when the participants provoked leakage by jumping and coughing.

The study was coordinated by Aino Fianu Jonasson, senior scientist at Karolinska University Hospital. (Ref. TVS1000)

Follow-up study (completed in March 2019)

In a follow-up study with women who participated in the clinical study, 75 % of the participants stated that Efemia improved their quality of life. Moreover, 68 % stated that they will continue to use the product after the end of the study and 82 % said that they would recommend it to a friend or colleague.

Aino Fianu Jonasson, senior scientist at Karolinska University Hospital, was the study’s scientific advisor. (Ref. TVS2000)

Follow-up study (completed in March 2019)

In a follow-up study with women who participated in the clinical study, 75 % of the participants stated that Efemia improved their quality of life. Moreover, 68 % stated that they will continue to use the product after the end of the study and 82 % said that they would recommend it to a friend or colleague.

Aino Fianu Jonasson, senior scientist at Karolinska University Hospital, was the study’s scientific advisor. (Ref. TVS2000)

Post-launch user study (completed in January 2019)

A post-launch study with Efemia that was conducted together with Aller Media, Sweden’s largest publisher of popular journals, showed a significant improvement in quality of life during usage by women with self-diagnosed SUI.

As much as 83 % of the participants stated that Efemia made their everyday life easier. The study included 40 women with an average age of 58 years. Of these, 30 participants completed the whole study. (Ref. TVS3000)

Two studies for evaluating Efemia during exercise (completed in August 2019)

New research shows that SUI is overrepresented among female athletes. Invent Medic has therefore conducted two after-market studies with specific focus on this target group. 21 women who experienced urine leakage during fitness (13) or crossfit (8) training participated in the studies. 100 % of the participants experienced that Efemia reduced their urine leakage, and 86 % stated that they see themselves continue to use the product.

The results are promising, and Invent Medic plans to follow up with additional studies focusing on this target group. (Ref. L. Chisholm et. Al. 2019, TVS4000 and TVS5000)

Two studies for evaluating Efemia during exercise (completed in August 2019)

New research shows that SUI is overrepresented among female athletes. Invent Medic has therefore conducted two after-market studies with specific focus on this target group. 21 women who experienced urine leakage during fitness (13) or crossfit (8) training participated in the studies. 100 % of the participants experienced that Efemia reduced their urine leakage, and 86 % stated that they see themselves continue to use the product.

The results are promising, and Invent Medic plans to follow up the with additional studies focusing on this target group. (Ref. L. Chisholm et. Al. 2019, TVS4000 and TVS5000)